Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 13,264,000 | 13,118,000 | 1,155,000 | 13,298,000 | 13,466,000 |
| Cost of Goods | 2,576,000 | 2,433,000 | 814,000 | 2,694,000 | 2,916,000 |
| Gross Profit | 10,688,000 | 10,685,000 | 341,000 | 10,604,000 | 10,550,000 |
| Operating Expenses | 6,422,000 | 6,271,000 | 6,358,000 | 6,840,000 | 6,574,000 |
| Operating Income | 4,266,000 | 4,414,000 | -6,017,000 | 3,764,000 | 3,976,000 |
| Other Income | -125,000 | -91,000 | -3,220,000 | 413,000 | 551,000 |
| Pre-tax Income | 4,141,000 | 4,323,000 | -9,237,000 | 4,177,000 | 4,527,000 |
| Income Tax | -915,000 | 433,000 | -1,536,000 | 66,000 | 648,000 |
| Net Income Continuous | 5,056,000 | 3,889,000 | -7,700,000 | 4,111,000 | 3,879,000 |
| Net Income Discontinuous | N/A | N/A | 7,318,000 | 11,000 | N/A |
| Minority Interests | 10,000 | 6,000 | 12,000 | 8,000 | 7,000 |
| Net Income | $5,046,000 | $3,883,000 | $-395,000 | $4,114,000 | $3,872,000 |
| EPS Basic Total Ops | 0.91 | 0.69 | -0.06 | 0.70 | 0.66 |
| EPS Basic Continuous Ops | 0.91 | 0.69 | -1.31 | 0.70 | 0.66 |
| EPS Basic Discontinuous Ops | N/A | N/A | 1.25 | 0.00 | N/A |
| EPS Diluted Total Ops | 0.89 | 0.68 | -0.06 | 0.69 | 0.65 |
| EPS Diluted Continuous Ops | 0.89 | 0.68 | -1.29 | 0.69 | 0.65 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 1.23 | 0.00 | N/A |
| EBITDA(a) | $5,794,000 | $5,959,000 | $-4,610,000 | $5,378,000 | $5,538,000 |